177 related articles for article (PubMed ID: 31817577)
1. Bioactivity Evaluation of a Novel Formulated Curcumin.
Liao SC; Hsu WH; Huang ZY; Chuang KL; Lin KT; Tseng CL; Tsai TH; Dao AH; Su CL; Huang CF
Nutrients; 2019 Dec; 11(12):. PubMed ID: 31817577
[TBL] [Abstract][Full Text] [Related]
2. A polymeric nanoparticle formulation of curcumin in combination with sorafenib synergistically inhibits tumor growth and metastasis in an orthotopic model of human hepatocellular carcinoma.
Hu B; Sun D; Sun C; Sun YF; Sun HX; Zhu QF; Yang XR; Gao YB; Tang WG; Fan J; Maitra A; Anders RA; Xu Y
Biochem Biophys Res Commun; 2015 Dec; 468(4):525-32. PubMed ID: 26482853
[TBL] [Abstract][Full Text] [Related]
3. Codelivery of sorafenib and curcumin by directed self-assembled nanoparticles enhances therapeutic effect on hepatocellular carcinoma.
Cao H; Wang Y; He X; Zhang Z; Yin Q; Chen Y; Yu H; Huang Y; Chen L; Xu M; Gu W; Li Y
Mol Pharm; 2015 Mar; 12(3):922-31. PubMed ID: 25622075
[TBL] [Abstract][Full Text] [Related]
4. Development and evaluation of self-microemulsifying liquid and pellet formulations of curcumin, and absorption studies in rats.
Setthacheewakul S; Mahattanadul S; Phadoongsombut N; Pichayakorn W; Wiwattanapatapee R
Eur J Pharm Biopharm; 2010 Nov; 76(3):475-85. PubMed ID: 20659556
[TBL] [Abstract][Full Text] [Related]
5. Using the Pleiotropic Characteristics of Curcumin to Validate the Potential Application of a Novel Gene Expression Screening Platform.
Liao SC; Hsu HW; Chuang KL; Huang ZY; Lin KT; Hsu WH; Chang KH; Huang CF; Su CL
Nutrients; 2019 Jun; 11(6):. PubMed ID: 31234318
[TBL] [Abstract][Full Text] [Related]
6. Enhanced oral bioavailability and anticancer activity of novel curcumin loaded mixed micelles in human lung cancer cells.
Patil S; Choudhary B; Rathore A; Roy K; Mahadik K
Phytomedicine; 2015 Nov; 22(12):1103-11. PubMed ID: 26547533
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma.
Cheng Y; Zhao P; Wu S; Yang T; Chen Y; Zhang X; He C; Zheng C; Li K; Ma X; Xiang G
Int J Pharm; 2018 Jul; 545(1-2):261-273. PubMed ID: 29730175
[TBL] [Abstract][Full Text] [Related]
8. A combination of complexation and self-nanoemulsifying drug delivery system for enhancing oral bioavailability and anticancer efficacy of curcumin.
Shukla M; Jaiswal S; Sharma A; Srivastava PK; Arya A; Dwivedi AK; Lal J
Drug Dev Ind Pharm; 2017 May; 43(5):847-861. PubMed ID: 27648633
[TBL] [Abstract][Full Text] [Related]
9. Preparation of curcumin-hydroxypropyl-β-cyclodextrin inclusion complex by cosolvency-lyophilization procedure to enhance oral bioavailability of the drug.
Li N; Wang N; Wu T; Qiu C; Wang X; Jiang S; Zhang Z; Liu T; Wei C; Wang T
Drug Dev Ind Pharm; 2018 Dec; 44(12):1966-1974. PubMed ID: 30059244
[TBL] [Abstract][Full Text] [Related]
10. Conundrum and therapeutic potential of curcumin in drug delivery.
Kumar A; Ahuja A; Ali J; Baboota S
Crit Rev Ther Drug Carrier Syst; 2010; 27(4):279-312. PubMed ID: 20932240
[TBL] [Abstract][Full Text] [Related]
11. Enhanced oral bioavailability of curcumin via a solid lipid-based self-emulsifying drug delivery system using a spray-drying technique.
Yan YD; Kim JA; Kwak MK; Yoo BK; Yong CS; Choi HG
Biol Pharm Bull; 2011; 34(8):1179-86. PubMed ID: 21804203
[TBL] [Abstract][Full Text] [Related]
12. Enhanced anti-hepatoma effect of a novel curcumin analog C086
Deng Y; Chen C; Xiao Z; Huang X; Xu J
Drug Deliv; 2020 Dec; 27(1):927-937. PubMed ID: 32597247
[TBL] [Abstract][Full Text] [Related]
13. Characterization, in Vivo and in Vitro Evaluation of Solid Dispersion of Curcumin Containing d-α-Tocopheryl Polyethylene Glycol 1000 Succinate and Mannitol.
Song IS; Cha JS; Choi MK
Molecules; 2016 Oct; 21(10):. PubMed ID: 27763524
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo evaluation of curcumin loaded lauroyl sulphated chitosan for enhancing oral bioavailability.
Shelma R; Sharma CP
Carbohydr Polym; 2013 Jun; 95(1):441-8. PubMed ID: 23618291
[TBL] [Abstract][Full Text] [Related]
15. Surface modification of solid lipid nanoparticles for oral delivery of curcumin: Improvement of bioavailability through enhanced cellular uptake, and lymphatic uptake.
Baek JS; Cho CW
Eur J Pharm Biopharm; 2017 Aug; 117():132-140. PubMed ID: 28412471
[TBL] [Abstract][Full Text] [Related]
16. Preparation and evaluation of curcumin-loaded self-assembled micelles.
Wang LL; He DD; Wang SX; Dai YH; Ju JM; Zhao CL
Drug Dev Ind Pharm; 2018 Apr; 44(4):563-569. PubMed ID: 29148846
[TBL] [Abstract][Full Text] [Related]
17. Formulation of curcumin delivery with functionalized single-walled carbon nanotubes: characteristics and anticancer effects in vitro.
Li H; Zhang N; Hao Y; Wang Y; Jia S; Zhang H; Zhang Y; Zhang Z
Drug Deliv; 2014 Aug; 21(5):379-87. PubMed ID: 24160816
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
[TBL] [Abstract][Full Text] [Related]
19. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy.
Mukerjee A; Vishwanatha JK
Anticancer Res; 2009 Oct; 29(10):3867-75. PubMed ID: 19846921
[TBL] [Abstract][Full Text] [Related]
20. Hansen solubility parameters (HSP) for prescreening formulation of solid lipid nanoparticles (SLN): in vitro testing of curcumin-loaded SLN in MCF-7 and BT-474 cell lines.
Doktorovova S; Souto EB; Silva AM
Pharm Dev Technol; 2018 Jan; 23(1):96-105. PubMed ID: 28949267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
